Effect of chronic magnesium supplementation on magnesium distribution in healthy volunteers evaluated by 31P-NMRS and ion selective electrodes
Wary C, Brillault-Salvat C, Bloch G, Leroy-Willig A, Roumenov D, Grognet JM, Leclerc JH, Carlier PG
British journal of clinical pharmacology · 29 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 1999-11-01 · Br J Clin Pharmacol · vol. 48 · número 5 · págs. 655–662
- Editorial
- Wiley
- Citado
- 40 citas · más que el 72% de estudios similares · 0.9× el promedio de su campo
- Referencias
- 39 trabajos
- Acceso
- Lectura gratuita
- Áreas de investigación
- Magnesium in Health and Disease · Magnesium Alloys: Properties and Applications · Magnesium Oxide Properties and Applications
- Palabras clave
- magnesium supplementation, intracellular magnesium, skeletal muscle, brain, urinary magnesium excretion, plasma magnesium, magnesium lactate, 31P NMR, ion-selective electrodes, healthy volunteers
- MeSH
- muscle, skeletal, brain, erythrocytes, humans, magnesium, tablets, blood chemical analysis, magnetic resonance spectroscopy, diet, double-blind method, reproducibility of results, tissue distribution, blood pressure, heart rate, algorithms, adult, male
10 autores
- Wary🇫🇷Institut de Myologie; Pitié-Salpêtrière Hospital
- Brillault‐Salvat🇫🇷Commissariat à l'Énergie Atomique et aux Énergies Alternatives
- Bloch🇫🇷Commissariat à l'Énergie Atomique et aux Énergies Alternatives
- Leroy‐Willig🇧🇪🇫🇷 · autor de correspondenciaUniversity of Liège; Institut de Myologie; Pitié-Salpêtrière Hospital
- Leroy‐Willig🇧🇪🇫🇷University of Liège; Commissariat à l'Énergie Atomique et aux Énergies Alternatives; Institut de Myologie; Pitié-Salpêtrière Hospital
- Roumenov🇫🇷Commissariat à l'Énergie Atomique et aux Énergies Alternatives
- Grognet🇧🇪🇫🇷University of Liège; Commissariat à l'Énergie Atomique et aux Énergies Alternatives
- Leclerc🇧🇪🇫🇷University of Liège; Commissariat à l'Énergie Atomique et aux Énergies Alternatives; Institut de Myologie; Pitié-Salpêtrière Hospital
- Leclerc🇧🇪🇫🇷 · autor de correspondenciaUniversity of Liège; Institut de Myologie; Pitié-Salpêtrière Hospital
- Carlier🇫🇷 · autor de correspondenciaCommissariat à l'Énergie Atomique et aux Énergies Alternatives
Resumen
El texto original del estudio, en el idioma en que se publicó.
Aims
The role of magnesium (Mg) intake in the prevention and treatment of diseases is greatly debated. Mg biodistribution after chronic Mg supplementation was investigated, using state-of-the-art technology to detect changes in free ionized Mg, both at extra- and intracellular levels.
Methods
Thirty young healthy male volunteers participated in a randomised, placebo (P)-controlled, double-blind trial. The treated group (MgS) took 12 mmol magnesium lactate daily for 1 month. Subjects underwent in vivo 31P-NMR spectroscopy and complete clinical and biological examinations, on the first and last day of the trial. Total Mg was measured in plasma, red blood cells and 24 h urine ([Mg]U ). Plasma ionized Mg was measured by ion-selective electrodes. Intracellular free Mg concentrations of skeletal muscle and brain tissues were determined noninvasively by in vivo 31P-NMR at 3T. NMR data were automatically processed with the dedicated software MAGAN.
Results
Only [Mg]U changed significantly after treatment (in mmol/24 h, for P, from 4.2+/-1.4 before to 4.1+/-1.3 after and, for MgS, from 3.9+/-1.1 before to 5. 1+/-1.1 after, t=2.15, P=0.04). The two groups did not differ, either before or after the trial, in any other parameter, whether clinical, biological or in relation with the Mg status.
Conclusions
Chronic oral administration of Mg tablets to young healthy male volunteers at usual pharmaceutical doses does not alter Mg biodistribution. This study shows that an adequate and very complete noninvasive methodology is now available and compatible with the organization of clinical protocols which aim at a thorough evaluation of Mg biodistribution.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.